Healthcare Provider Networking Patients Transportation 
Clarify Health
OCTOBER 10, 2023
When building provider networks, it is crucial to include providers who can assess and address social determinants to ensure that care is equitable, patient-centered, and effective in improving health outcomes and reducing healthcare disparities.
Impetus Digital
JANUARY 30, 2023
Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. But without patients, there would be no need for pharmaceuticals at all.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Impetus Digital
AUGUST 24, 2023
Smart hospitals are elevating patient care and revolutionizing hospital operations like never before. Each one contributes distinctively towards streamlining and making the healthcare system more patient-centric. For instance, IoT devices enable real-time patient monitoring and personalized care.
Clarivate
APRIL 24, 2023
Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients.
PM360
SEPTEMBER 7, 2023
10 As healthcare communicators, we prioritize patients, as we should. Healthcare brands must have intentional programs to communicate information to caregivers effectively, especially for those with health literacy, education, or language barriers.
pharmaphorum
JANUARY 24, 2023
Energy crisis effects will be felt across healthcare, but for medicines manufacturing and delivery the issue is especially complex because the networks of medicine supply extend across the globe and across countries which see differing impacts of energy costs and supply. Medicines manufacturing is energy intensive.
Clarify Health
OCTOBER 26, 2021
By enrolling participants with a wide range of baseline characteristics, study populations will more accurately reflect the patients likely to take the drug if it is approved. Cancer patients treated in clinical trials live substantially longer than those not treated in trials and benefit from lower hospital readmissions. 2] Figure 1.
Expert insights. Personalized for you.
59 
Let's personalize your content